<p>Modeled changes in CD4 count for surviving patients initiating antiretroviral therapy during 2004–2007.</p
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
<p>CD4 cell count evolution after initiation of antiretroviral treatment stratified by period (2003–...
<p>Changes in CD4 count of patients with HIV, over time, according to the variables in the final mul...
<p>Predicted one year mortality by average imputed CD4 count at antiretroviral therapy initiation as...
CD4+ count is used to assess the clinical status of HIV-infected patients and making informed decisi...
<p>Change in CD4 count from baseline for AIDS patients at 6 months for the four treatment regimens.<...
<p>Change in CD4 count from baseline for AIDS patients at 12 months for the four treatment regimens....
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
* the values for patients who started treatment with absolute CD4 between 500 and 650/μl and >650/μl...
<p>Change in CD4 count from baseline for non-AIDS patients at 6 months for the four treatment regime...
BackgroundCD4 cell counts is widely used as a biomarker for treatment progression when studying the ...
After initiation of a treatment for human immunodeficiency virus type 1 infection containing a prote...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
<p>CD4 cell count evolution after initiation of antiretroviral treatment stratified by period (2003–...
<p>Changes in CD4 count of patients with HIV, over time, according to the variables in the final mul...
<p>Predicted one year mortality by average imputed CD4 count at antiretroviral therapy initiation as...
CD4+ count is used to assess the clinical status of HIV-infected patients and making informed decisi...
<p>Change in CD4 count from baseline for AIDS patients at 6 months for the four treatment regimens.<...
<p>Change in CD4 count from baseline for AIDS patients at 12 months for the four treatment regimens....
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
* the values for patients who started treatment with absolute CD4 between 500 and 650/μl and >650/μl...
<p>Change in CD4 count from baseline for non-AIDS patients at 6 months for the four treatment regime...
BackgroundCD4 cell counts is widely used as a biomarker for treatment progression when studying the ...
After initiation of a treatment for human immunodeficiency virus type 1 infection containing a prote...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
DOI
Add to ORKG